Home › Funds › Artisan Partners Limited Partnership › WST

Artisan Partners Limited Partnership position in WST

WEST PHARMACEUTICAL SVSC INC · Health Care

Artisan Partners Limited Partnership reported holding 2,007,802 shares of WST (WEST PHARMACEUTICAL SVSC INC) in its Q3 2026 13F filing — a position valued at US$744.4M, representing 1.38% of its reported portfolio and ranking #20 among its reported holdings. Artisan Partners Limited Partnership has disclosed WST holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.01M sh
Reported value held$744.42M
Portfolio Weight1.38%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Artisan Partners Limited Partnership's WST position evolved

Artisan Partners Limited Partnership first disclosed a stake in WST in Q3 2023 at 1,591,271 shares (US$597.1M). The position peaked in Q4 2024 at 3,110,903 shares, worth US$1.02B. Across 13 filings, Artisan Partners Limited Partnership increased the stake 8 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,007,802 shares valued at US$744.4M — a reduction of -403,990 shares quarter over quarter.. Notable position changes include a 29% trim in Q1 2025 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.59M $597.06M New
Q4 2023 1.96M $690.53M Add
Q1 2024 2.07M $817.75M Add
Q2 2024 2.49M $820.80M Add
Q3 2024 3.07M $920.45M Add
Q4 2024 3.11M $1.02B Add
Q1 2025 2.20M $491.52M Reduce
Q2 2025 2.27M $496.09M Add
Q3 2025 2.77M $726.90M Add
Q4 2025 2.85M $784.26M Add
Q1 2026 2.66M $666.17M Reduce
Q2 2026 2.41M $865.83M Reduce
Q3 2026 2.01M $744.42M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About WST and 13F data

WST (WEST PHARMACEUTICAL SVSC INC) is a Health Care company. 27 other funds we track also report a position in WST — the largest reported positions include GENERATION INVESTMENT MANAGEMENT LLP (US$728.2M), BROWN ADVISORY INC (US$386.0M), Longview Partners (Guernsey) LTD (US$371.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding WST

All WST fund holders →

FAQ

How long has Artisan Partners Limited Partnership held WST?

Artisan Partners Limited Partnership has disclosed WST holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Artisan Partners Limited Partnership's current position in WST?

As of Q3 2026, Artisan Partners Limited Partnership holds 2.01M shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $744.42M, representing 1.38% of its reported portfolio and ranking #20.

Has Artisan Partners Limited Partnership been buying or selling WST?

In the latest 13F filing (Q3 2026), Artisan Partners Limited Partnership reduced its position in WST. The position peaked in Q4 2024 at 3.11M shares.

Which other funds hold WST?

Other major institutional holders of WST include GENERATION INVESTMENT MANAGEMENT LLP, BROWN ADVISORY INC, Longview Partners (Guernsey) LTD, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.